Immunisation of pigs with recombinant HEV vaccines does not protect from infection with HEV genotype 3

Hepatitis E virus (HEV) is a major cause of acute viral hepatitis worldwide. Up to now, no approved treatment nor a globally licensed vaccine is available. Several recombinant HEV vaccines have been developed to protect against HEV infection in humans, including the commercially available Hecolin va...

Full description

Bibliographic Details
Main Authors: Lisa Dähnert, Elmira Aliabadi, Christine Fast, Isabella Hrabal, Charlotte Schröder, Patrick Behrendt, Ulrike Protzer, Martin H. Groschup, Martin Eiden
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:One Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352771423001945